Business
Eisai is applying for full FDA approval for Reuters’ Alzheimer’s drug Leqembi
Eisai is applying for full FDA approval for Reuters’ Alzheimer’s drug Leqembi
#Eisai #applying #full #FDA #approval #Reuters #Alzheimers #drug #Leqembi Welcome to Alaska Green Light Blog, here is the new story we have for you today:
Click Me To View Restricted Videos
©Reuters. FILE PHOTO: The Eisai Co Ltd logo is displayed on March 8, 2018 at the company’s headquarters in Tokyo, Japan. REUTERS/Issei Kato/File Photo
(Reuters) – Japanese drugmaker Eisai Co (OTC:) Ltd said on Saturday it had submitted an application to the US Food and Drug Administration for a standard review of its Alzheimer’s drug Leqembi, which was recently submitted under the agency’s expedited review process was approved.
